Leukaemia drug shows potential for rare type of ovarian cancer (clear cell/dasatinib/ARIDIA)

press release
June 30, 2016 

The mutation is found in around half of patients diagnosed with ovarian clear cell carcinoma. 

 

References

*Miller et al., Synthetic Lethal Targeting of ARID1A mutant ovarian clear cell tumours with dasatinib. Molecular Cancer Therapeutics, 2016don’t yet know exactly how it is linked to cancer.